Looking back over the past 12 months, Information Technology was heads and shoulders the best-performing sector.

FBR (ASX:FBR) has completed its Demonstration Program in Florida, showcasing the capabilities of its Hadrian X robotic ...

Mesoblast specialises in developing medicines that treat severe inflammatory conditions. Their technology is being applied to conditions like chronic heart failure and chronic low back pain.

Shaw and Partners Chief Investment Officer Martin Crabbe outlines a four-part investment strategy, focusing on growth, financial conditions, central bank policy and valuation. He notes that ...

Simberi Gold Company, a wholly-owned subsidiary of St Barbara (ASX:SBM), has received a $210m tax assessment from Papua New Guinea’s Internal Revenue Commission.

Avita Medical has announced FDA approval for its new RECELL GO mini disposable cartridge. Spray-on skin The original RECELL platform received FDA approval in 2018 for severe burns ...

Larvotto Resources (ASX:LRV) has reported final results from its reverse circulation drilling program at the Clarks Gully deposit, which is part of the company's Hillgrove Gold-Antimony Project in ...

Austal (ASX:ASB) has been awarded a $137.02m contract to construct two additional Evolved Cape-class Patrol Boats (ECCPBs) for the Australian Border Force (ABF). This extension brings the total ...

Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and ...

This week saw a flurry of activity in the small-cap market, with exciting developments in biotech, energy, and litigation funding. Here’s a snapshot of the stocks making headlines. INOVIQ (ASX ...

Global shares were mixed over the last week with a back up in bond yields and a bit of profit taking after a strong run up weighing on US and Eurozone shares leading to small falls. Chinese shares ...